Revisiting Neuroblastoma: Nrf2, NF-κB and Phox2B as a Promising Network in Neuroblastoma
Open Access
- 6 April 2024
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (4) , 3193-3208
Abstract
Neuroblastoma is the most common solid extracranial tumor during childhood; it displays extraordinary heterogeneous clinical courses, from spontaneous regression to poor outcome in high-risk patients due to aggressive growth, metastasizing, and treatment resistance. Therefore, the identification and detailed analysis of promising tumorigenic molecular mechanisms are inevitable. This review highlights the abnormal regulation of NF-κB, Nrf2, and Phox2B as well as their interactions among each other in neuroblastoma. NF-κB and Nrf2 play a key role in antioxidant responses, anti-inflammatory regulation and tumor chemoresistance. Recent studies revealed a regulation of NF-κB by means of the Nrf2/antioxidant response element (ARE) system. On the other hand, Phox2B contributes to the differentiation of immature sympathetic nervous system stem cells: this transcription factor regulates the expression of RET, thereby facilitating cell survival and proliferation. As observed in other tumors, we presume striking interactions between NF-κB, Nrf2, and Phox2B, which might constitute an important crosstalk triangle, whose decompensation may trigger a more aggressive phenotype. Consequently, these transcription factors could be a promising target for novel therapeutic approaches and hence, further investigation on their regulation in neuroblastoma shall be reinforced.Keywords
This publication has 108 references indexed in Scilit:
- NF‐κB signaling in inflammation and cancerMedcomm, 2021
- The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?Cellular and Molecular Life Sciences, 2021
- Fumonisin B1 alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cellsArchives of Toxicology, 2021
- Molecular targeting therapies for neuroblastoma: Progress and challengesMedicinal Research Reviews, 2020
- Nrf2 in cancers: A double‐edged swordCancer Medicine, 2019
- Histone Methyltransferase Setd7 Regulates Nrf2 Signaling Pathway by Phenethyl Isothiocyanate and Ursolic Acid in Human Prostate Cancer CellsMolecular Nutrition & Food Research, 2018
- Structural and functional differences inPHOX2Bframeshift mutations underlie isolated or syndromic congenital central hypoventilation syndromeHuman Mutation, 2017
- The metastatic microenvironment: Lung‐derived factors control the viability of neuroblastoma lung metastasisInternational Journal of Cancer, 2013
- Children's Oncology Group's 2013 blueprint for research: NeuroblastomaPediatric Blood & Cancer, 2012
- Tumor resistance to apoptosisInternational Journal of Cancer, 2008